These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2441448)

  • 61. [Cases of familial leukemia-lymphoma in Szabolcs-Szatmár-Bereg County].
    Jakó J; Szerafin L; Póth I; Nagy P; Smanykó D; Babicz T
    Orv Hetil; 1992 Jan; 133(3):147-8, 153. PubMed ID: 1734343
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The clinical significance of chromosomal changes in acute leukemia.
    Bloomfield CD
    Prog Clin Biol Res; 1985; 177():153-70. PubMed ID: 3892539
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biotherapy with interferon in hematologic malignancies.
    Roth MS; Foon KA
    Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569
    [No Abstract]   [Full Text] [Related]  

  • 64. The current status of cancer chemotherapy for selected human neoplasms.
    Rubin RN
    Clin Ther; 1981; 4(2):74-94. PubMed ID: 7028265
    [No Abstract]   [Full Text] [Related]  

  • 65. Maintenance immunotherapy of acute non-lymphocytic leukaemia using unirradiated blast cells and B.C.G.
    Fennelly JJ; McBride A; O'Connell LG
    Biomedicine; 1976 Jul; 25(6):198-9. PubMed ID: 963181
    [No Abstract]   [Full Text] [Related]  

  • 66. [Analysis of prognostic factors and predictive models of response to induction chemotherapy in acute non-lymphoblastic leukemia].
    Lorenzo JI; Martín-Aragonés G; Rafecas FJ; Martínez JA; Sanz G; Gomis F; Sanz MA
    Med Clin (Barc); 1987 Jun; 89(4):135-40. PubMed ID: 3626658
    [No Abstract]   [Full Text] [Related]  

  • 67. Therapy of chronic myelogenous leukemia: chemotherapy and interferons.
    Talpaz M; Kantarjian HM; Kurzrock R; Gutterman J
    Semin Hematol; 1988 Jan; 25(1):62-73. PubMed ID: 2450402
    [No Abstract]   [Full Text] [Related]  

  • 68. The management of leukaemia and allied disorders.
    Innes JI
    Scott Med J; 1975 Jan; 20(1):1-2. PubMed ID: 1053845
    [No Abstract]   [Full Text] [Related]  

  • 69. Report of Children's Cancer Study Group.
    Rowley JD
    J Clin Oncol; 1985 Jan; 3(1):1-2. PubMed ID: 3965627
    [No Abstract]   [Full Text] [Related]  

  • 70. [Perspectives for the use of gene therapy in blood disorders].
    Jedrzejczak WW
    Pol Arch Med Wewn; 2002 May; 107(5):475-9. PubMed ID: 12189921
    [No Abstract]   [Full Text] [Related]  

  • 71. Who should treat acute leukemia?
    Holland JF
    JAMA; 1969 Sep; 209(10):1511-3. PubMed ID: 5257713
    [No Abstract]   [Full Text] [Related]  

  • 72. Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia.
    Khodadoust MS; Luo B; Medeiros BC; Johnson RC; Ewalt MD; Schalkwyk AS; Bangs CD; Cherry AM; Arai S; Arber DA; Zehnder JL; Gotlib J
    Leukemia; 2016 Apr; 30(4):947-50. PubMed ID: 26055304
    [No Abstract]   [Full Text] [Related]  

  • 73. Immunology Letters. IMmune-related Pathologies: Understanding Leukocyte Signaling and Emerging Therapies--IMPULSE 2013. Introduction.
    Erdei A; Sármay G; Matkó J; Prechl J
    Immunol Lett; 2014 Aug; 160(2):107-8. PubMed ID: 24721899
    [No Abstract]   [Full Text] [Related]  

  • 74. Current prospects for clinical care of acute leukemia.
    Henderson ES
    Haematol Blood Transfus; 1983; 28():156-60. PubMed ID: 6190714
    [No Abstract]   [Full Text] [Related]  

  • 75. Leukemia and lymphoma in the elderly.
    Kennedy BJ
    Front Radiat Ther Oncol; 1986; 20():150-6. PubMed ID: 3512372
    [No Abstract]   [Full Text] [Related]  

  • 76. [Acute and chronic leukemias. Current aspects of pathogenesis, diagnosis and therapy].
    Buske C; Hiddemann W
    Internist (Berl); 2002 Oct; 43(10):1177-8. PubMed ID: 12524899
    [No Abstract]   [Full Text] [Related]  

  • 77. Molecular diagnosis and monitoring of leukemia and lymphoma.
    Borden EC; Waalen J; Liberati AM; Grignani F
    Leuk Res; 1993 Dec; 17(12):1073-8. PubMed ID: 8246612
    [No Abstract]   [Full Text] [Related]  

  • 78. Liver damage after chemotherapy for leukemia and lymphoma.
    AMROMIN GD; DELIMAN RM; SHANBROM E
    Gastroenterology; 1962 Apr; 42():401-10. PubMed ID: 13861044
    [No Abstract]   [Full Text] [Related]  

  • 79. [Chemotherapy in leukemia and malignant reticulosis].
    ARIENS EJ
    Ned Tijdschr Geneeskd; 1959 Sep; 103():1919-22. PubMed ID: 13794222
    [No Abstract]   [Full Text] [Related]  

  • 80. Features suggesting curability in lymphoma and leukemia.
    Burchenal JH
    CA Cancer J Clin; 1973; 23(6):344-53. PubMed ID: 4203040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.